Thailand Advanced Bipolar Direct Energy Devices Market Analysis

The Thailand Advanced Bipolar Direct Energy Devices Market size stood at around xx Bn in 2023 and is projected to reach US $xx Bn by 2033, exhibiting a CAGR of xx% during the forecast period.

The Thailand Advanced Bipolar Direct Energy Devices Market Executive Summary

Bipolar direct energy devices are apparatuses used to develop heat energy through conversion of high frequency and alternating current through the body of a patient. These may be employed for incising, coagulating, fulgurating, or desiccating tissue. The Advanced Bipolar Direct Energy Devices are primarily employed in the two applications including skin lesion therapy and therapies in gastroenterology and gynaecological surgeries. These devices also enable precise application of energy to the target area and exclude the risk of harming the other parts of the tissue and may lead to burns.

The global market for advanced bipolar direct energy devices is projected to continue to grow at a steady rate due to the increasing technological development of the products and quickly shifting health industry trends in favour non-invasive procedures. Some of the key players in the market include Medtronic, Johnson & Johnson, and others dominate the market, with North America holding the largest share given its highly developed healthcare system. The potential threats include high costs and challenges in managing regulations which could hinder future growth. All in all, the market is growing because of the increasing need for effective and safer surgical procedures.    

Thailand Advanced Bipolar Direct Energy Devices Market Dynamics

Market Growth Drivers

The rising prevalence of chronic diseases and the tendency toward less invasive surgical procedures are the key factors behind the demand for sophisticated bipolar direct energy devices. These devices are essential in laparoscopic operations, and as such, they continue to receive technological updates. The enhanced surgeon awareness, higher overall expenditure in healthcare, and significantly increased R&D expenditure are also bolstering the growth of the market.

Opportunity

For future developments of advanced bipolar direct energy devices, possibilities include their introduction into interventional radiology and cardiac surgery, technological developments involving enhanced energy management and digitalization, and market expansion in Asian-Pacific, Latin American, and Middle East & African markets. 

Market Restraints

The concerns for advanced bipolar direct energy devices are higher cost that raises device expense and restricts usage and strict rules and regulations that further slowdown approvals and increase compliance costs. Lack of compensation might prevent healthcare facilities from implementing these technologies in their systems, as well as the scarcity of trained specialists capable of working with these devices would also be limiting factors. Furthermore, other risks imply a possibility of complications including thermal injuries that may result in hesitancy from the surgeons and healthcare facilities. 

Competitive Landscape for Advanced Bipolar Direct Energy Devices Market in Thailand

Key Players

• Medtronic PLC
• B. Braun Melsungen AG
• Bovie Medical Corporation
• Johnson & Johnson
• XCELLANCE Medical Technologies
• Olympus Corporation
• Karl Storz SE & Co. KG

Recent Developments:

August 2024, Olympus Corporation introduced two new jaw designs in its POWERSEAL™ Sealer/Divider line: the POWERSEAL Straight Jaw, Double-action (SJDA) and the POWERSEAL Curved Jaw, Single-action (CJSA). Building on the success of the POWERSEAL Curved Jaw, Double-action (CJDA) launched in 2021, these new devices aim to strengthen Olympus's presence in the advanced bipolar surgical energy market.

September 2022, Olympus Corporation  released the THUNDERBEAT™ Open Fine Jaw Type X surgical energy device, featuring a new thermal shield for enhanced safety in open surgeries. The device is currently available in Japan, with plans for a commercial launch in Europe, the U.S., and South Korea in October 2022, followed by additional regions.

June 2021, Ethicon part of the Johnson & Johnson Medical Devices Companies announced the ENSEAL X1 Curved Jaw Tissue Sealer launch. This new advanced bipolar energy device increases procedural efficiency1 and provides stronger sealing2 and better access to more tissue than LigaSure Maryland. 

Mergers and Acquisitions

December 2022, Olympus Corporation announced it has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company with a strong portfolio of commercially available computer-aided detection/diagnostic (CAD) solutions and a deep innovation pipeline of cloud-enabled applications, for up to GBP 66 million (approx. 11 billion JPY / 79 million USD) in upfront and milestone-based payments.

Healthcare Policies and Regulatory Landscape for Advanced Bipolar Direct Energy Devices Market in Thailand

Policy changes and Reimbursement scenario

Future policies could advance bipolar direct energy development by improving approval requirements, safety measures, and reimbursement categories. Public authorities could contribute to demand for minimally invasive surgeries by providing funds and following policies; developing regions may further expand ownership of these technologies through investments in health care systems. Also, incentives for research may encourage innovations and therefore, bring out new products into the market.